Evidence map›Paper›PMID 38899337›Full record

ArticleHaematologica2024

Clifford M Csizmar, Mark Gurney, Rashmi Kanagal-Shamanna, Kelly Chien, Danielle Hammond, Terra L Lasho, Christy M Finke, Christopher Dean, Anuya Natu, Abhishek A Mangaonkar and 10 more

Abstract readLetter
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Prognostic implications ofBlood neoplasia · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Clifford M CsizmarDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Mark GurneyDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Rashmi Kanagal-ShamannaDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Kelly ChienDivision of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Danielle HammondDivision of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Terra L LashoDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Christy M FinkeDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Christopher DeanDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Anuya NatuDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Abhishek A MangaonkarDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Aref Al-KaliDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Naseema GangatDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Ayalew TefferiDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Hassan AlkhateebDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Guillermo Garcia-ManeroDivision of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Rami S KomrokjiDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
Najla A AliDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
Eric PadronDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
Guillermo Montalban-BravoDivision of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Mrinal M PatnaikDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN. patnaik.mrinal@mayo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllelesDioxygenasesDNA-Binding ProteinsLeukemia, Myelomonocytic, ChronicMutationProto-Oncogene ProteinsRepressor ProteinsFemaleGenotypeHumansMalePrognosisRisk AssessmentASXL1 protein, humanDioxygenasesDNA-Binding ProteinsProto-Oncogene ProteinsRepressor ProteinsTET2 protein, human

Identifiers

PMID38899337
PMCPMC11443373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.